A critical examination of the mode of action of quinacrine in the reproductive tract in a 2-year rat cancer bioassay and its implications for human clinical use.
暂无分享,去创建一个
[1] M. Luster,et al. Quinacrine-induced occlusive fibrosis in the human fallopian tube is due to a unique inflammatory response and modification of repair mechanisms. , 2013, Journal of reproductive immunology.
[2] P. Feldblum,et al. Pelvic surgery and hospitalization among Chilean women after nonsurgical sterilization with quinacrine pellets between 1977 and 1989. , 2012, Contraception.
[3] S. Feller,et al. Beyond DNA binding - a review of the potential mechanisms mediating quinacrine's therapeutic activities in parasitic infections, inflammation, and cancers , 2011, Cell Communication and Signaling.
[4] M. Schuler,et al. Evaluation of phenolphthalein, diazepam and quinacrine dihydrochloride in the in vitro mammalian cell micronucleus test in Chinese hamster ovary (CHO) and TK6 cells. , 2010, Mutation research.
[5] D. Weiner,et al. Quinacrine Sterilization and Gynecologic Cancers: A Case–Control Study in Northern Vietnam , 2010, Epidemiology.
[6] E. Zeiger,et al. An alternative interpretation of, "A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats". , 2010, Regulatory toxicology and pharmacology : RTP.
[7] D. Creasy,et al. A lifetime cancer bioassay of quinacrine administered into the uterine horns of female rats. , 2010, Regulatory toxicology and pharmacology : RTP.
[8] D. Weiner,et al. Safety of quinacrine contraceptive pellets: results from 10-year follow-up in Vietnam. , 2008, Contraception.
[9] J. Matés,et al. Intracellular redox status and oxidative stress: implications for cell proliferation, apoptosis, and carcinogenesis , 2008, Archives of Toxicology.
[10] W. Denny,et al. Genotoxicity of non-covalent interactions: DNA intercalators. , 2007, Mutation research.
[11] T. Wang,et al. Stem cells and cancer. , 2007, Seminars in cancer biology.
[12] D. Hattis,et al. Issues in the Design and Interpretation of Chronic Toxicity and Carcinogenicity Studies in Rodents: Approaches to Dose Selection , 2007, Critical reviews in toxicology.
[13] B. Aggarwal,et al. Inflammation and cancer: how hot is the link? , 2006, Biochemical pharmacology.
[14] D. Sokal,et al. A One-Year Neonatal Mouse Carcinogenesis Study of Quinacrine Dihydrochloride , 2006, International journal of toxicology.
[15] J. K. Kundu,et al. Breaking the relay in deregulated cellular signal transduction as a rationale for chemoprevention with anti-inflammatory phytochemicals. , 2005, Mutation research.
[16] Lutz Müller,et al. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity. , 2005, Mutation research.
[17] A. Mantovani,et al. Cancer: Inflammation by remote control , 2005, Nature.
[18] A. Mantovani,et al. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. , 2005, Cancer cell.
[19] A. Camargos,et al. Quinacrine female nonsurgical sterilization (QS): endometrial assessment by vaginal ultrasonography in 128 women , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[20] J. Lippes,et al. An FDA phase I clinical trial of quinacrine sterilization (QS) , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[21] M. Kamel,et al. Hysteroscopic and hysterosalpingographic study after intrauterine insertion of quinacrine pellets for non‐surgical sterilization: results in 180 women , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[22] W. Lu,et al. A comparison of quinacrine sterilization (QS) and surgical sterilization (TL) in 600 women in Guizhou Province, China , 2003, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.
[23] L. Coussens,et al. Inflammation and cancer , 2002, Nature.
[24] D. Phillips,et al. Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway , 2002, Oncogene.
[25] K J O'Byrne,et al. Chronic immune activation and inflammation as the cause of malignancy , 2001, British Journal of Cancer.
[26] V. O. Wagner,et al. Re-evaluation of the mutagenic potential of quinacrine dihydrochloride dihydrate. , 2001, Mutation research.
[27] D. Casciano,et al. Neonatal Mouse Model: Review of Methods and Results , 2001, Toxicologic pathology.
[28] D. Sokal,et al. Cancer risk among women sterilized with transcervical quinacrine in Chile: an update through 1996. , 2000, Fertility and sterility.
[29] A. Krishnaja,et al. Quinacrine dihydrochloride, the non-surgical female sterilant induces dicentrics, rings, and marker chromosomes in human peripheral blood lymphocytes treated in vitro: a preliminary report. , 2000, Mutation research.
[30] P. Fail,et al. Comparative effects of quinacrine and erythromycin in adult female rats: a nonsurgical sterilization study. , 2000, Fertility and sterility.
[31] E Zeiger,et al. Identification of rodent carcinogens and noncarcinogens using genetic toxicity tests: premises, promises, and performance. , 1998, Regulatory toxicology and pharmacology : RTP.
[32] P. Fu,et al. Neonatal mouse assay for tumorigenicity: alternative to the chronic rodent bioassay. , 1997, Regulatory toxicology and pharmacology : RTP.
[33] L. Laufe,et al. Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets. , 1996, Contraception.
[34] H. Muto,et al. Primary dermal and eye irritability tests of hydrophobically modified hydroxypropyl methylcellulose in rabbits. , 1992, The Journal of toxicological sciences.
[35] A. El-Kady,et al. Histopathologic changes in the cornual portion of the fallopian tube following a single transcervical insertion of quinacrine hydrochloride pellets , 1991, Advances in contraception : the official journal of the Society for the Advancement of Contraception.
[36] J. Ashby,et al. Overview of the study in relation to protocol design for the rodent bone-marrow micronucleus assay. , 1990, Mutation research.
[37] M. Ishidate,et al. Micronucleus test on quinacrine dihydrochloride in mice: a comparison of dosage regimens. , 1990, Mutation research.
[38] D. Wallace. The use of quinacrine (Atabrine) in rheumatic diseases: a reexamination. , 1989, Seminars in arthritis and rheumatism.
[39] L. Zaneveld,et al. Lack of tubal occlusion by intrauterine quinacrine and tetracycline in the primate. , 1984, Contraception.
[40] T. Parmley,et al. Effect of intrauterine administration of tetracyclines on cynomolgus monkeys. , 1984, Contraception.
[41] B. Hartley‐åsp,et al. Induction of micronuclei in the mouse. Revised timing of the final stage of erythropoiesis. , 1983, Mutation research.
[42] C. Chao,et al. Haemolytic anaemia in rhesus monkeys induced by methylcellulose , 1982, Laboratory animals.
[43] L. Laufe,et al. Quinacrine-induced pathologic changes in the fallopian tube. , 1980, Fertility and sterility.
[44] D. Boggs,et al. Kinetics of the development of methylcellulose-induced hepatic hematopoiesis in adult mice. , 1978, Blood.
[45] C Ramel,et al. The induction of micronuclei by frameshift mutagens at the time of nucleus expulsion in mouse erythroblasts. , 1974, Mutation research.
[46] M. Medel,et al. Human Fertility Control by Transvaginal Application of Quinacrine on the Fallopian Tube , 1970 .
[47] B. Lozzio,et al. Erythrocyte destruction induced by methylcellulose. , 1966, Archives of pathology.
[48] C. Hall,et al. Glomerulonephritis and hypertension produced by parenteral administration of methylcellulose. , 1962, The American journal of pathology.
[49] R. Fisher,et al. Statistical Methods for Research Workers , 1930, Nature.
[50] E Kessel,et al. Clinicopathologic study of fallopian tube closure after single transcervical insertion of quinacrine pellets. , 1995, International journal of fertility and menopausal studies.
[51] M. Osman,et al. Hysteroscopic and hysterosalpingographic study after intrauterine insertion of quinacrine pellets for non-surgical sterilization. , 1992, Advances in contraceptive delivery systems : CDS.
[52] E. Zeiger,et al. Salmonella mutagenicity tests: IV. Results from the testing of 300 chemicals , 1988, Environmental and molecular mutagenesis.
[53] T. Parmley,et al. Teratologic and mutagenic studies with intrauterine quinacrine hydrochloride. , 1983 .
[54] T. Parmley,et al. Quinacrine hydrochloride: future research. , 1983 .
[55] W. Schmid,et al. The non-induction of micronuclei by quinacrine. , 1975, Mutation research.
[56] F. James Rohlf,et al. Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .
[57] T. B. Teoh. The effects of methyl cellulose in rats with special reference to splenomegaly, anaemia and the problem of hypersplenism. , 1961, The Journal of pathology and bacteriology.